Trial Profile
A Phase 1 Dose Escalation/Expansion Study of BLZ-100 Administered by Intravenous Injection in Adult Subjects With Glioma Undergoing Surgery
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Apr 2020
Price :
$35
*
At a glance
- Drugs Tozuleristide (Primary)
- Indications Glioma; Solid tumours
- Focus Adverse reactions
- Sponsors Blaze Bioscience
- 09 May 2019 According to a Blaze Bioscience media release, results from the study have been published in the peer-reviewed journal Neurosurgery.
- 09 May 2019 Results presented in a Blaze Bioscience media release.
- 05 Jun 2018 Results (n=42) evaluating PK parameters in 2 clinical studies (NCT02234297 and NCT02462629) presented at the 54th Annual Meeting of the American Society of Clinical Oncology